UCB Art Show: Building Bridges
The 2026 UCB Mito Global Art Show brought the creativity and voices of the global mitochondrial disease community into the spotlight—a wonderful achievement that […]
Uncategorized
Introducing SynLeigh: a new project on treatment development for Leigh Syndrome
Coordinated by Professor Alessandro Prigione and funded through the European Rare Diseases Research Alliance (ERDERA), SynLeigh will study sildenafil and
The Effects of Hydrogen Sulfide, VOCs and Bioaerosols on People with Mitochondrial Disease
Written by Paula Morandi, Chair of IMP Why emissions from olive‑pomace fermentation pose a serious health risk The open‑air fermentation
A note from the Chair: One Voice, 25 Nations — The Power of Our Global Umbrella
Paula Morandi, Chair of IMP When you hear the acronym IMP, what comes to mind? To many, International Mito Patients
World Mitochondrial Disease Week 2026: Putting Mito on the Map
We’re delighted to announce the launch of this year’s World Mitochondrial Disease Week theme: “Putting Mito on the Map.” Members asked
European Rare Disease Conference Calls for Stronger Cooperation Across Member States
On 3–4 June 2026, the 13th edition of the European Conference on Rare Diseases and Orphan Products took place in
Uncategorized
Global Mito Map Privacy Notice
Last updated: 19th June 2026 Who We Are The International Mito Patients (IMP) operates the Global Mito Map as part
The role of amino acids in some forms of mito
On May 9, 2026, International Mito Patients was represented at the Cognate Amino Acid for tRNA Synthetase Disorders Consortium meeting
IMP Welcomes New Members from China, Spain and US
We are delighted to announce that three additional mitochondrial organisations have joined IMP, further strengthening our global network and amplifying
IMP Welcomes FDA Approval of First-Ever Treatment for TK2d
IMP Welcomes FDA Approval of First-Ever Treatment for TK2d International Mito Patient (IMP) is delighted to welcome yesterday’s approval by